4/10/2026NHSA Launches First Public Disclosure for Reference Drug Pre-Communica...

4/10/2026CDE Seeks Comments on New Technical Guideline for Staged Manufacturing...

4/10/2026China Unveils Sweeping Measures to Accelerate Tiered Healthcare System...

4/10/2026Xuanzhu Expands Global Oncology Reach With Boston Oncology Licensing D...

4/10/2026DualityBio Wins China BLA Acceptance for HER2 Breast Cancer ADC, Movin...

4/10/2026IMPACT Thera Secures $5M Milestone as PARP1-Selective IMP1734 Advances...

4/10/2026Oricell Raises Over $110M Pre-IPO to Advance Global Solid Tumor CAR-T ...

4/9/2026CDE Releases New Clinical Evaluation Guideline for IND Applications to...

4/9/2026CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...

4/9/2026Syneron Emerges as a Macrocycle Powerhouse as Funding and AZ Deal Fuel...

4/9/2026Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...

More>>

4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...

4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...

4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...

4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)

4/7/2026China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...

4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...

4/1/2026Biotech VCs Move Upstream in China as Competition for Innovation Inten...

3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...

3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...

3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...

3/17/2026China to Grant Market and Data Exclusivity for Innovative Drugs for th...

More>>